Views of parents and pharmacists following participation in a paediatric pharmacovigilance study
- 132 Downloads
Objective To explore the experiences and views of community pharmacists and parents participating in a prospective paediatric pharmacovigilance study. Method Twenty-five pharmacists and 32 parents were approached for telephone interview. Interviews were audio-recorded, transcribed and analysed thematically to identify recurring issues and themes. Results Seventeen pharmacists and 22 parents were interviewed. Parents and pharmacists agreed that more information about the side effects of medicines in children was required. Both groups reported willingness to participate in future prospective pharmacovigilance studies, although pharmacists expressed concerns about the lack of financial incentives. Pharmacists reported that parents had concerns regarding the confidentiality of their child’s ADR data and the study data collection process. Conclusion This study highlighted positive and negative opinions of parents and pharmacists regarding their experiences in this research project. Maintaining confidentiality in relation to indication and medicines prescribed were important issues for parents whereas time constraints and lack of financial incentives were key issues influencing participation by community pharmacists.
KeywordsAdverse drug reactions Community pharmacists Experiences Parents Pharmacovigilance Scotland Telephone interviews Views
We would like to thank all the parents and community pharmacists who took part in this research and administration staff at Aberdeen University.
We acknowledge funding provided by the Scottish Chief Scientist’s Office (CSO).
Conflicts of interest
There were no conflicts of interest.
- 1.BMA. Reporting adverse drug reactions—a BMA policy document. BMA, London. 1996. http://www.bma.org.uk/images/ADRFinal_tcm41-20713.pdf. Accessed 22 Dec 2009.
- 3.Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994. J R Coll Phys Lond. 1995;29(1):41–9.Google Scholar
- 5.Carleton BC, Smith MA, Gelin MN, Heathcote SC. Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol. 2006;14(1):45–57.Google Scholar
- 7.Cox A. Embracing ADR reporting could improve pharmacists’ standing. Pharm J. 2002;269:14.Google Scholar
- 8.Tobaiqy M, Bond C, Helms P, Lee A, Stewart D, McCaig D, Bateman N A, McLay JS. A pilot study to evaluate a community pharmacy based monitoring system to identify adverse drug reactions associated with paediatric medicines use. Eu J Clin Pharm. 2010. doi: 10.1007/s00228-010-0790-9.
- 11.Armour C, Brillant M, Krass I. Pharmacists’ views on involvement in pharmacy practice research: strategies for facilitating participation. Pharm Pract. 2007;5(2):59–66.Google Scholar